Vertaling van "compared to currently available " (Nederlands → Frans) :

The extensive Phase III program for this product has demonstrated statistically superior improvements in lung function and COPD symptoms, especially breathlessness, compared to currently available bronchodilators, including the market leader tiotropium.
Le vaste programme de phase III pour ce produit a apporté, par comparaison avec les bronchodilatateurs courants, dont tiotropium le leader du marché, la preuve d’améliorations plus importantes de la fonction pulmonaire et des symptômes de la BPCO, en particulier concernant l’essoufflement.

improvement of the information compared with the former situation when In the field of mental health, the currently available indicators do not reflect the medical workforce was estimated by the total number of licensed the recent major changes in the sector.
Current head counts of practising physicians undoubtedly represent an In the field of mental health, the currently available indicators do not reflect improvement of the information compared with the former situation when the recent major changes in the sector.

QAB149 (indacaterol), a bronchodilator in development for Chronic Obstructive Pulmonary Disease (COPD), has been shown in Phase III clinical trials to significantly improve lung function over the currently available treatments formoterol and tiotropium at three months of therapy.
QAB149 (indacatérol), un bronchodilatateur en développement pour traiter la bronchopneumopathie chronique obstructive (BPCO), a montré, dans des essais cliniques de phase III que, au bout de trois mois, il améliorait notablement la fonction pulmonaire par rapport aux traitements à base de formotérol et tiotropium disponibles actuellement.

Cash outflows from investing activities amounted to USD 14.2 billion in 2009 compared to USD 10.4 billion in 2008, as lower capital expenditures of USD 1.9 billion (which declined to 4.3% of net sales in 2009 compared to 5.1% in 2008) was more than offset by investments in marketable securities and increased investments totaling USD 12.3 billion in intangible, non-current and financial assets, including the EBEWE Pharma generics acquisition.
Les sorties de trésorerie liées aux activités d’investissement se sont élevées, en 2009, à USD 14,2 milliards, contre USD 10,4 milliards en 2008, car les investissements en immobilisations corporelles ont diminué à USD 1,9 milliard (en baissant à 4,3% du chiffre d’affaires net en 2009 contre 5,1% en 2008). Cette diminution a été plus que compensée par des investissements dans des titres de placement négociables et par une hausse des investissements d’USD 12,3 milliards dans des immobilisations incorporelles, des actifs non courants et financiers, y compris l’acquisition du secteur des génériques d’EBEWE Pharma.

computer simulation model the Netherlands Ministry of Health Minimal counselling alone Minimal counselling+NRT Intensive counselling+NRT Intensive counselling+bupropion Telephone counselling Comparator: current practice: 25% of all smokers would follow a smoking cessation program, current practice: 1.3% of smokers uses one of the interventions.
computer simulation model the Netherlands Ministry of Health Minimal counselling alone Minimal counselling+NRT Intensive counselling+NRT Intensive counselling+Buproprion Telephone counselling Comparator: current practice: 25% of all smokers would follow a smoking cessation program, current practice: 1.3% of smokers uses one of the interventions.

The drug has been shown previously to significantly reduce the relapse rate compared to intra-muscular interferon beta 1a, the current standard of care, and also to delay disability progression versus placebo.
Ce médicament a démontré sa capacité de réduire considérablement le taux de rechute comparé à l’interféron bêta 1a en injection intramusculaire, la norme actuelle de soin, et aussi de retarder la progression de l’invalidité par rapport à un placebo.

Consistent with this focused research strategy, new Phase II data demonstrates that ACZ885, currently marketed as Ilaris for the rare disease cryopyrin-associated periodic syndrome (CAPS), provided highly statistically significant risk reduction of acute flares in gout patients compared to the anti-inflammatory standard of care.
Cette approche stratégique est illustrée par ACZ885, un médicament actuellement commercialisé sous la marque Ilaris pour traiter le syndrome périodique associé à la cryopirine (CAPS), une maladie rare. De nouveaux résultats d’une étude de phase II ont montré que ce médicament induisait une réduction importante, hautement significative sur le plan statistique, du risque de crises aiguës de goutte par comparaison avec le traitement anti-inflammatoire standard.

From a medical perspective, the majority of current health problems in poor countries can be controlled; effective preventive and curative treatments are available, most of them at reasonable prices.
D’un point de vue strictement médical, la majorité des maladies présentes dans les pays pauvres pourraient être jugulées : de nombreux traitements préventifs et thérapeutiques efficaces sont en effet disponibles, le plus souvent à bas prix.

Zortress/Certican (USD 35 million, +19% cc), a transplantation medicine to prevent organ rejection in adult kidney and heart transplantation, continues to grow based on its availability in more than 80 countries and its US launch for adult kidney transplantation in April, 2010, under the brand name Zortress and is currently in two Phase III studies with global participation in heart transplantation, and also a worldwide study for liver transplantation.
Certican/Zortress (USD 35 millions, +19% tcc) est un médicament destiné à prévenir le rejet des organes dans les transplantations du rein et du cœur chez l’adulte.

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).